The Leadership Team at Acrigen Biosciences guides the strategic direction and operational execution of the company's gene-editing initiatives. Comprised of seasoned experts, including the CEO and Chief Technology Officer, this team oversees research priorities, technology development, and collaboration with scientific advisory boards to drive innovation and navigate the pathway to commercialization of cutting-edge therapies for genetic disorders.
View all